Aug 06, 2025

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

Jul 23, 2025

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time

Jul 22, 2025

Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D

Jun 11, 2025

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Jun 10, 2025

Lantheus to Present at the 2025 Truist Securities MedTech Conference

Jun 03, 2025

Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 07, 2025

Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update

May 06, 2025

Lantheus Announces Sale of SPECT Business to SHINE Technologies

Apr 30, 2025

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies